0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

News From the Food and Drug Administration | 
Rita Rubin, MA
JAMA. 2015;313(17):1704. doi:10.1001/jama.2015.4114.

Editorial | 
Charles L. Campbell, MD; David J. Moliterno, MD
JAMA. 2015;313(8):801-802. doi:10.1001/jama.2015.0567.

Original Investigation | 
Anne-Marie Schjerning Olsen, MD, PhD; Gunnar H. Gislason, MD, PhD; Patricia McGettigan, MD; et al.
JAMA. 2015;313(8):805-814. doi:10.1001/jama.2015.0809.
Includes: Supplemental Content

Original Investigation | 
Barthelemy Diouf, PharmD, PhD; Kristine R. Crews, PharmD; Glen Lew, MD; et al.
JAMA. 2015;313(8):815-823. doi:10.1001/jama.2015.0894.
Includes: Supplemental Content

Viewpoint | 
Marc B. Garnick, MD
JAMA. 2015;313(6):563-564. doi:10.1001/jama.2014.17334.

Viewpoint | 
Muthiah Vaduganathan, MD, MPH; Vinay Prasad, MD, MPH
JAMA. 2014;312(24):2619-2620. doi:10.1001/jama.2014.15221.
Includes: Supplemental Content

Viewpoint | 
Paul C. Mullan, MD, MPH; David O. Kessler, MD, MSc; Adam Cheng, MD, FRCPC
JAMA. 2014;312(22):2333-2334. doi:10.1001/jama.2014.15741.

Original Investigation |  FREE
Lana A. Castellucci, MD; Chris Cameron, MSc; Grégoire Le Gal, MD, PhD; et al.
JAMA. 2014;312(11):1122-1135. doi:10.1001/jama.2014.10538.
Includes: Supplemental Content

JAMA Patient Page |  FREE
Jill Jin, MD, MPH
JAMA. 2014;312(11):1167. doi:10.1001/jama.2014.2078.
Includes: Supplemental Content

From The Medical Letter on Drugs and Therapeutics | 
JAMA. 2014;312(9):955-957. doi:10.1001/jama.2014.10644.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Original Investigation  | 
Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma
Neha Korde, MD; Mark Roschewski, MD; Adriana Zingone, MD, PhD; et al.
JAMA Psychiatry
Editorial  | 
Antipsychotic Use in Youth Without Psychosis: A Double-edged Sword
Christoph U. Correll, MD; Joseph C. Blader, PhD
JAMA Psychiatry
Original Investigation  | 
Treatment of Young People With Antipsychotic Medications in the United States
Mark Olfson, MD, MPH; Marissa King, PhD; Michael Schoenbaum, PhD
JAMA Neurology
Viewpoint  | 
The Importance of Lesbian, Gay, Bisexual, and Transgender Health in Neurology: What’s in a Name?
Nicole Rosendale, MD; S. Andrew Josephson, MD